Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

HST-1/FGF-4 plays a critical role in crypt cell survival and facilitates epithelial cell restitution and proliferation

Abstract

The fibroblast growth factor-4 (HST-1/FGF-4) is a heparin-binding growth factor that influences on epithelial and many other cells through interaction with FGF receptors. It has been demonstrated that the HST-1/FGF-4 gene protects mice from lethal irradiation by preventing bone marrow damage and intestinal tract damage. However, the radioprotective mechanism is unknown. In this study, we have investigated the expression of Hst-1/Fgf-4 in mouse small intestine after irradiation, and determined the role of HST-1/FGF-4 in mouse intestinal crypt cell survival and epithelial cell proliferation and restitution. We found the induction of endogenous Hst-1/Fgf-4 expression in intestine when mice are exposed to 9.0 Gy irradiation. Laser-captured microdissection (LCM) coupled with RT–PCR analysis revealed that expression of Hst-1/Fgf-4 was found in epithelial cell of the villi and crypt cells. Pretreatment of HST-1/FGF-4 caused an increase in the number of surviving crypt cells, and clearly suppresses the radiation-induced apoptosis of the crypt cells. Moreover, exogenous HST-1/FGF-4 enhances epithelial cell restitution and proliferation in an in vitro model. These data suggest that HST-1/FGF-4 is induced by irradiation injury, and that HST-1/FGF-4 will find a therapeutic role in the prevention of intestinal cell toxicity following intensive chemotherapy and radiation therapy protocols, and in allogenic cell transplantation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Arman E, Haffner-Krausz R, Chen Y, Heath JK and Lonai P . (1998). Proc. Natl. Acad. Sci. USA, 95, 5082–5087.

  • Aviezer D, Safran M and Yayon A . (1999). Biochem. Biophys. Res. Commun., 263, 621–626.

  • Bach SP, Renehan AG and Potten CS . (2000). Carcinogenesis, 21, 469–476.

  • Ciacci C, Lind SE and Podolsky DK . (1993). Gastroenterology, 105, 93–101.

  • Cohn SM, Schloemann S, Tessner T, Seibert K and Stenson WF . (1997). J. Clin. Invest., 99, 1367–1379.

  • Cohn SM, Simon TC, Roth KA, Birkenmeier EH and Gordon JI . (1992). J. Cell Biol., 119, 27–44.

  • Cutler NS, Graves-Deal R, LaFleur BJ, Gao Z, Boman BM, Whitehead RH, Terry E, Morrow JD and Coffey RJ . (2003). Cancer Res., 63, 1748–1751.

  • Dignass AU and Podolsky DK . (1993). Gastroenterology, 105, 1323–1332.

  • Dignass AU, Tsunekawa S and Podolsky DK . (1994). Gastroenterology, 106, 1254–1262.

  • Deroanne CF, Hajitou A, Calberg-Bacq CM, Nusgens BV and Lapiere CM . (1997). Cancer Res., 57, 5590–5597.

  • Farrell CL, Bready JV, Rex KL, Chen JN, DiPalma CR, Whitcomb KL, Yin S, Hill DC, Wiemann B, Starnes CO, Havill AM, Lu ZN, Aukerman SL, Pierce GF, Thomason A, Potten CS, Ulich TR and Lacey DL . (1998). Cancer Res., 58, 933–939.

  • Feil W, Wenzl E, Vattay P, Starlinger M, Sogukoglu T and Schiessel R . (1987). Gastroenterology, 92, 1973–1986.

  • Feldman B, Poueymirou W, Papaioannou VE, DeChiara TM and Goldfarb M . (1995). Science, 267, 246–249.

  • Hughes SE and Hall PA . (1993). Lab. Invest., 69, 173–182.

  • Houchen CW, George RJ, Sturmoski MA and Cohn SM . (1999). Am. J. Physiol., 276, G249–G258.

  • Khan WB, Shui C, Ning S and Knox SJ . (1997). Radiat. Res., 148, 248–253.

  • Lacy ER . (1988). J. Clin. Gastroenterol., 10 (Suppl 1), 72–77.

  • Li YQ, Fan CY, O'Connor PJ, Winton DJ and Potten CS . (1992). Carcinogenesis, 13, 361–368.

  • Leigh BR, Khan W, Hancock SL and Knox SJ . (1995). Radiat. Res., 142, 12–15.

  • McCormack SA, Viar MJ and Johnson LR . (1992). Am. J. Physiol., 263 (Part 1), G426–G435.

  • Nusrat A, Delp C and Madara JL . (1992). J. Clin. Invest., 89, 1501–1511.

  • Ochiya T . (1997). J. Toxicol. Pathol., 10, 129–132.

  • Okunieff P, Mester M, Wang J, Maddox T, Gong X, Tang D, Coffee M and Ding I . (1988). Radiat. Res., 150, 204–211.

  • Paris F, Fuks Z, Kang A, Capodieci P, Juan G, Ehleiter D, Haimovitz-Friedman A, Cordon-Cardo C and Kolesnick R . (2001). Science, 293, 293–297.

  • Potten CS . (1990). Int. J. Radiat. Biol., 58, 925–973.

  • Potten CS, Booth D and Haley JD. . (1997). Br. J. Cancer, 75, 1454–1459.

  • Potten CS and Loeffler M . (1990). Development, 110, 1001–1020.

  • Potten CS, Li YQ, O'Connor PJ and Winton DJ . (1992). Carcinogenesis, 13, 2305–2312.

  • Potten CS, Rezvani M, Hendry JH, Moore JV and Major D . (1981). Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med., 40, 321–326.

  • Roberts DB, Travis EL and Tucker SL . (1993). Radiat. Res., 135, 56–63.

  • Sakamoto H, Ochiya T, Sato Y, Tsukamoto M, Konishi H, Saito I, Sugimura T and Terada M . (1994). Proc. Natl. Acad. Sci. USA, 91, 12368–12372.

  • Santos MF, McCormack SA, Guo Z, Okolicany J, Zheng Y, Johnson LR and Tigyi G . (1997). J. Clin. Invest., 100, 216–225.

  • Takahama Y, Ochiya T, Tanooka H, Yamamoto H, Sakamoto H, Nakano H and Terada M . (1999). Oncogene, 18, 5943–5947.

  • Wambersie A, Smeesters P and Fruhling J . (1996). Rev. Med. Brux., 17, 75–84.

  • Winton DJ and Ponder BA . (1990). Proc. R. Soc. Lond. B Biol. Sci., 241, 13–18.

  • Withers HR and Elkind MM . (1970). Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med., 17, 261–267.

  • Wright JA and Huang A . (1996). Histol. Histopathol., 11, 521–536.

  • Yoshida T, Ishimaru K, Sakamoto H, Yokota J, Hirohashi S, Igarashi K, Sudo K and Terada M . (1994). Cancer Lett., 83, 261–268.

Download references

Acknowledgements

We gratefully acknowledge Dr Hiroyuki Daiko (Genetics Division, National Cancer Center Institute, Japan) for kind assistance. We thank Ms Masako Hosoda, Ms Kaoru Yoshida, and Ms Kazumi Kimura for their excellent technical work. This work was supported in part by a Grant-Aid for the Second-Term Comprehensive 10-Year Strategy for Cancer Control, Health Science Research Grants for the Research on Human Genome and Gene Therapy from the Ministry of Health, Labour, and Welfare of Japan, and Gene Therapy from the Ministry of Health, Labor and Welfare of Japan, and a Grant-in-Aid by Japan Owner's association.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Takahiro Ochiya.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sasaki, H., Hirai, K., Yamamoto, H. et al. HST-1/FGF-4 plays a critical role in crypt cell survival and facilitates epithelial cell restitution and proliferation. Oncogene 23, 3681–3688 (2004). https://doi.org/10.1038/sj.onc.1207348

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207348

Keywords

This article is cited by

Search

Quick links